ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OPTH vs ALLR // FREE CASH FLOW YIELD

Optimi Health Corp. (NASDAQ) VS. Allarity Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: OPTH 1 — ALLR 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OPTH VS. ALLR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OPTH ALLR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -35.00% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE — — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality — 2/9 — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 18.3 38.9 -20.54 ALLR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $14.9M $14.2M $726.7K OPTH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OPTH REV ALLR REV OPTH GROSS % ALLR GROSS % OPTH FCF ALLR FCF
FY 2025 — $0 — — — -$14.8M
FY 2024 — $0 — — — -$17.6M
FY 2023 — $0 — — — -$12.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OPTH // BETA —
ALLR // BETA —